Abstract Library

#1680 PD-1, PD-L1 and PD-L2 Expression in Well-Differentiated Small Bowel Gastrointestinal Neuroendocrine Tumours (Wd SB-NETs).

Introduction: Treatment options for patients with advanced Wd SB-NETs are limited.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Lamarca A

Authors: Lamarca A, Nonaka D, Breitwieser W, Ashton G, Barriuso J,

Keywords: immunotherapy,

#1545 In Vivo Expression of Survivin and XIAP in Medullary Thyroid Carcimoma

Introduction: Medullary thyroid carcinoma (MTC) accounts for approximately 5 % of all thyroid malignancies. Although surgery remains the first line therapy with curative intention, for advanced MTC current chemotherapeutic regimes do not provide promising results. Consequently, the identification of biologically relevant biomarkers that are associated with MTC progression may provide novel therapeutic targets.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Werner T

Authors: Werner T, Riemer J, Dizdar L, Wolf A, Cupisti K,

Keywords: MTC, IAP, survivin, XIAP,

#1362 Targeting Tumor Metabolism in NETs: A Novel Mechanism of Action of the Somatostatin Analog Lanreotide

Introduction: One of the hallmarks of cancer is reprogramming of energy metabolism, characterized by a shift to aerobic glycolysis. This metabolic switch provides cancer cells appropriate conditions required for enhanced proliferation and survival. The effects of somatostatin on tumor metabolism had not been determined yet.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Wolf I

Authors: Wolf I, Hesin A, Rubinstein T, Rubinek T, Shabtay-Orbach A,

Keywords: metabolism, glucose,

#169 Radio guided surgery in neuroendocrine tumours using 68Ga-labeled somatostatin analogs – a pilot study.

Introduction: Radioguided surgery (RGS) is an intraoperative localizing technique for the detection of cancer tissue using tumor-specific radionuclides.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Kaemmerer D, Prasad V, Daffner W, Baum R, Hommann M,

Keywords: neuroendocrine tumors, 68Ga-somatostatin receptor analogs, PET/CT, radio-guided surgery,

#13 Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic carcinoma

Introduction: Pancreatic endocrine tumors (pNETs) are rare but are among the most common neuroendocrine neoplasms of the abdomen. At diagnosis, many of them are already advanced and difficult to treat.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Kaemmerer D, Vikas P, Daffner W, Hörsch D, Klöppel G,

Keywords: endocrine pancreatic carcinoma, peptide receptor radionuclide therapy, neodjuvant treatment, pancreatic surgery, molecular imaging, receptor PET/CT,